RZJ-91495-02112
3 vaccinations
1 coded response
35 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 843 / UT
- Registered
- 2021-01-06
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-06
Registered in v-safe
-
2021-01-06
Dose 1 — Moderna
- 2021-01-06
-
2021-01-07
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-01-08
- 2021-01-09
- 2021-01-10
- 2021-01-11
- 2021-01-12
- 2021-01-13
- 2021-01-20
- 2021-01-27
- 2021-02-03
-
2021-02-04
Dose 2 — Moderna
- 2021-02-10
- 2021-02-11
- 2021-02-18
- 2021-02-25
- 2021-03-06
- 2021-03-13
- 2021-03-18
- 2021-05-06
-
2021-08-05
Survey response — 6 months, dose 2MedDRA: Conjunctivitis, Nasopharyngitis — Feeling: GoodFree text: Cold like symptoms, pink eyeMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-10-27
Dose 3 — Moderna
- 2021-10-27
- 2021-10-28
- 2021-10-29
- 2021-10-30
- 2021-10-31
- 2021-11-01
- 2021-11-02
- 2021-11-03
- 2021-11-10
- 2021-11-17
- 2021-11-24
- 2021-12-01
- 2021-12-08
- 2022-01-26
- 2022-04-27
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-06 | Moderna | |
| 2 | 2021-02-04 | Moderna | |
| 3 | 2021-10-27 | Moderna | No |
Free text
Release 9 — 6 months, dose 2
Symptoms: Cold like symptoms, pink eye
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Conjunctivitis | ✓ | · | ✓ |
| SD | Nasopharyngitis | ✓ | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release